Rajendran Ranjith, Sherry Leighann, Lappin David F, Nile Chris J, Smith Karen, Williams Craig, Munro Carol A, Ramage Gordon
Infection and Immunity Research Group, Glasgow Dental School, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, 378 Sauchiehall Street, Glasgow, G2 3JZ, UK.
Institute of Healthcare Associated Infection, School of Health, Nursing and Midwifery, University of the West of Scotland, Paisley, UK.
BMC Microbiol. 2014 Dec 5;14:303. doi: 10.1186/s12866-014-0303-6.
Biofilm formation by Candida albicans has shown to be highly variable and is directly associated with pathogenicity and poor clinical outcomes in patients at risk. The aim of this study was to test the hypotheses that the extracellular DNA release by C. albicans is strain dependent and is associated with biofilm heterogeneity.
Initially, biofilm formed by C. albicans high biofilm formers (HBF) or low biofilm formers (LBF) were treated with DNase to find whether eDNA play a role in their biofilm formation. Digestion of biofilm eDNA significantly reduced the HBF biofilm biomass by five fold compared to untreated controls. In addition, quantification of eDNA over the period of biofilm formation by SYBR green assay demonstrate a significantly higher level of 2 to 6 fold in HBF compared to LBF. Biochemical and transcriptional analyses showed that chitinase activity and mRNA levels of chitinase genes, a marker of autolysis, were upregulated in 24 h biofilm formation by HBF compared to LBF, indicating autolysis pathway possibly involved in causing variation. The biofilm biomass and eDNA release by single (∆cht2, ∆cht3) and double knockout (∆cht2/∆cht3) chitinase mutants were significantly less compared to their parental strain CA14, confirming the role of chitinases in eDNA release and biofilm formation. Correlation analysis found a positive correlation between chitinases and HWP1, suggesting eDNA may release during the hyphal growth. Finally, we showed a combinational treatment of biofilms with DNase or chitinase inhibitor (acetazolamide) plus amphotericin B significantly improved antifungal susceptibility by 2 to 8 fold.
Collectively, these data show that eDNA release by C. albicans clinical isolates is variable and is associated with differential biofilm formation. Digestion of biofilm eDNA by DNase may provide a novel therapeutic strategies to destabilise biofilm growth and improves antifungal sensitivity.
白色念珠菌形成生物膜的能力表现出高度变异性,且与高危患者的致病性及不良临床预后直接相关。本研究的目的是验证以下假设:白色念珠菌释放的细胞外DNA具有菌株依赖性,并与生物膜异质性相关。
最初,用脱氧核糖核酸酶处理由白色念珠菌高生物膜形成株(HBF)或低生物膜形成株(LBF)形成的生物膜,以探究细胞外DNA在其生物膜形成中是否起作用。与未处理的对照相比,生物膜细胞外DNA的消化使HBF生物膜生物量显著降低了五倍。此外,通过SYBR绿分析法对生物膜形成过程中的细胞外DNA进行定量分析,结果显示HBF中的细胞外DNA水平比LBF高2至6倍。生化和转录分析表明,与LBF相比,HBF在24小时生物膜形成过程中几丁质酶活性及几丁质酶基因的mRNA水平上调,几丁质酶是自溶的标志物,这表明自溶途径可能参与了变异的产生。与亲本菌株CA14相比,单敲除(∆cht2、∆cht3)和双敲除(∆cht2/∆cht3)几丁质酶突变体的生物膜生物量和细胞外DNA释放量显著减少,证实了几丁质酶在细胞外DNA释放和生物膜形成中的作用。相关性分析发现几丁质酶与HWP1之间存在正相关,表明细胞外DNA可能在菌丝生长过程中释放。最后,我们发现用脱氧核糖核酸酶或几丁质酶抑制剂(乙酰唑胺)联合两性霉素B处理生物膜,可使抗真菌敏感性显著提高2至8倍。
总体而言,这些数据表明白色念珠菌临床分离株释放的细胞外DNA具有变异性,并与生物膜形成差异有关。用脱氧核糖核酸酶消化生物膜细胞外DNA可能为破坏生物膜生长及提高抗真菌敏感性提供一种新的治疗策略。